Krsnaa Diagnostics Intrinsic Value
Krsnaa Diagnostics (KRSNAA) median intrinsic value is ₹612.50 from 9 valuation models (range ₹329–₹1082), vs current price ₹541.15 — +13.2% upside (Trading Below Median Value), margin of safety 11.6%. See KRSNAA P/B ratio history to compare market price against book value per share.
KRSNAA Valuation Methods Summary — DCF, Graham Number & P/E
Krsnaa Diagnostics intrinsic value across 9 models vs current price ₹541.15 — upside/downside and value range per method. Check Krsnaa Diagnostics networth to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹617.28 | ₹493.82 - ₹740.74 | +14.1% | EPS: ₹51.44, Sector P/E: 12x |
| Book Value Method | asset | ₹612.50 | ₹551.25 - ₹673.75 | +13.2% | Book Value/Share: ₹612.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹448.00 | ₹403.20 - ₹492.80 | -17.2% | Revenue/Share: ₹560.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1082.30 | ₹974.07 - ₹1190.53 | +100.0% | EBITDA: ₹344.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹566.54 | ₹453.23 - ₹679.85 | +4.7% | CF Growth: 8.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹329.22 | ₹296.30 - ₹362.14 | -39.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹423.87 | ₹381.48 - ₹466.26 | -21.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1082.30 | ₹974.07 - ₹1190.53 | +100.0% | ROE: 17.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹841.97 | ₹757.77 - ₹926.17 | +55.6% | EPS: ₹51.44, BVPS: ₹612.50 |
KRSNAA Intrinsic Value vs Market Price — All Valuation Models
Krsnaa Diagnostics fair value range ₹329–₹1082 vs current market price ₹541.15 across 9 valuation models. For current market price and key ratios, visit KRSNAA stock price BSE.
KRSNAA Intrinsic Value Analysis — Undervalued or Overvalued?
Krsnaa Diagnostics median intrinsic value ₹612.50, current price ₹541.15 — Trading Below Median Value by 13.2%, margin of safety 11.6%.
What is the intrinsic value of KRSNAA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krsnaa Diagnostics (KRSNAA) is ₹612.50 (median value). With the current market price of ₹541.15, this represents a +13.2% variance from our estimated fair value.
The valuation range spans from ₹329.22 to ₹1082.30, indicating ₹329.22 - ₹1082.30.
Is KRSNAA undervalued or overvalued?
Based on our multi-method analysis, Krsnaa Diagnostics (KRSNAA) appears to be trading below median value by approximately 13.2%.
KRSNAA Financial Health — Key Ratios vs Industry Benchmarks
Krsnaa Diagnostics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.30 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 17.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.49x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
KRSNAA Cash Flow Quality — Operating & Free Cash Flow
Krsnaa Diagnostics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹87 Cr | ₹37 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹24 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹76 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹128 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2017 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |